ATTRI Orthopaedics is a South African startup pioneering the development of advanced tumour and trauma reconstruction implants. Founded in 2012, the company has made significant strides in designing custom implants for pelvic reconstructions, as well as re-developing modular implants for upper and lower limbs.
One of ATTRI's key strengths lies in its collaborative efforts with various departments of the University of Cape Town (UCT) and the Central University of Technology (CUT). This strategic partnership focuses on improving manufacturing processes for implants, identifying new technologies, selecting materials, and developing osseo-integration techniques. It's worth noting that ATTRI does not engage in manufacturing directly, instead, it leverages the expertise of specialized subcontractors.
Their manufacturing needs are met through partnerships with CRPM, an ISO13485 certified unit of CUT, for 3D printing manufacturing, and TiTaMED, an ISO and CE certified company in Cape Town known for producing detailed and accurate medical, aerospace, and astronomical devices and instruments.
The last known investment in ATTRI Orthopaedics was a grant investment of ZAR580.00K received on 07 December 2018 from the Technology Innovation Agency. This investment serves as a testament to the potential and promise of the company in the health care industry.
In conclusion, ATTRI Orthopaedics is poised for continued growth and innovation in the field of orthopedic implants, supported by strong partnerships, strategic subcontracting, and a recent investment injection.